Hisashi Takei1,2, Sridhar Radhakrishnan3, Ikei Kobayashi2, Susumu Kobayashi2,4,5 (1.Department of Hematology, Gunma University Graduate School of Medicine, Japan, 2.Beth Israel Deaconess Medical Center and Harvard Medical School, USA, 3.Cancer Science Institute of Singapore, SINGAPORE, 4.Harvard Stem Cell Institute, Harvard Medical School, USA, 5.Division of Translational Genomics, National Cancer Center Japan)
Session information
Poster Session
Sat. Oct, 13
Poster Session 2-4 AML: Clinical (2)
Sat. Oct 13, 2018 5:30 PM - 6:10 PM Poster1 (Osaka International Convention Center, 3F Event Hall)
Chair: Masaharu Nohgawa (Department of Hematology, Japanese Red Cross Socirty Wakayama Medical center)
Nobuhiko Kobayashi1, Hiroaki Shimizu1, Kenichi Tahara2, Yohei Osaki3, Kunio Yanagisawa1, Takuma Ishizaki1, Yoshiyuki Ogawa1, Tomomi Sekigami4, Hirono Iriuchishima1, Hiromi Koiso1, Makiko Takizawa1, Akihiko Yokohama4, Takayuki Saitoh5, Norifumi Tsukamoto3, Hirokazu Murakami5, Hiroshi Handa1 (1.Department of Hematology, Gunma University, Gunma, Japan, 2.Department of Hematology, Shibukawa Medical Center, Shibukawa, Japan., 3.Oncology Center, Gunma University Hospital, Gunma, Japan, 4.Department of Blood Transfusion Service, Gunma University Hospital, Gunma, Japan, 5.Gunma University Graduate School of Health Science, Gunma, Japan)
Masuho Saburi1, Kazuhito Itani1, Takako Satou2, Yumi Inoue2, Yasuhiro Soga2, Yoshiyuki Kondo3, Kazuhiro Kohno1, Toshiyuki Nakayama1 (1.Department of Hematology, Oita Kouseiren Tsurumi Hospital, Oita, Japan, 2.Department of Clinical Laboratory, Oita Kouseiren Tsurumi Hospital, Oita, Japan, 3.Department of Diagnostic Pathology, Oita Kouseiren Tsurumi Hospital, Oita, Japan)
Kenjiro Tadagaki, Kenta Yamasaki, Noriko Kondo, Yasumichi Kuwahara, Tatsushi Yoshida, Tsukasa Okuda (Dept. Biochem. Molec. Biol., Kyoto Pref. Univ. Med, Kyoto, Japan)
Jia, Wenmin Han, Xiaohui Cai, Xiuwen Zhang, Rong Xiao, Jie Liu, Meiyu Chen, Xuzhang Lu (Tha affiliated Changzhou No.2 People's Hosptial of Nanjing Medical University, Changzhou, People's Republic of China)
Mitsuteru Hiwatari1,2, Kentaro Watanabe1, Shunsuke Kimura1, Masahiro Sekiguchi1, Yasuo Kubota1, Akira Oka1, Junko Takita1 (1.Cell Therapy and Transplantation Medicine, Tokyo Univ., Tokyo, Japan, 2.Pediatrics, Tokyo Univ., Tokyo, Japan)
Motomi Osato1,2, Kelly Ooi Kee Ong2, Michelle Meng Huang Mok2, Tomomasa Yokomizo1, Takayoshi Matsumura2, Toshio Suda1,2, Norio Asou3, Phillip Koeffler2, Daniel G. Tenen2, Ritsuko Shimizu4, Masayuki Yamamoto4, Ito Yoshiaki2, Allen Eng-Juh Yeoh2, Wee Joo Chng2 (1.IRCMS, Kumamoto Univ., Kumamoto, Japan, 2.Natl Univ Singapore, Singapore, 3.Saitama Medical Univ, Japan, 4.Tohoku Univ, Sendai, Japan)
Delia Dima, Ciprian Tomuleasa (Ion Chiricuta Oncology Institute, Cluj Napoca, Roumania)